Glucocerebrosidase mutations in diffuse Lewy body disease()

Clinicogenetic and pathological studies have shown that mutations of the glucocerebrosidase gene (GBA) are a risk factor for Parkinson’s disease and Lewy body disorders. In the present study, we have identified GBA mutations in 6.8% (4/59) of cases with a pathological diagnosis of diffuse Lewy body...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Parkinsonism Relat Disord
Autori principali: Nishioka, Kenya, Ross, Owen A., Vilariño-Güell, Carles, Cobb, Stephanie A., Kachergus, Jennifer M., Mann, David M.A., Snowden, Julie, Richardson, Anna M.T., Neary, David, Robinson, Christopher A., Rajput, Alex, Papapetropoulos, Spiridon, Mash, Deborah C., Pahwa, Rajesh, Lyons, Kelly E., Wszolek, Zbigniew K., Dickson, Dennis W., Farrer, Matthew J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721925/
https://ncbi.nlm.nih.gov/pubmed/20971030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.09.009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi